Suchergebnisse - "Bhore, Rafia"

PubPharm (86)

1

Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR) : 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Lanzetta, P. | Korobelnik, J. | Heier, J. | +22

2

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON) : 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

enthalten in: Lancet (London, England) | 2024

von Brown, D. | Boyer, D. | Do, D. | +124

3

Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

enthalten in: The New England journal of medicine | 2023

von Spiera, R. | Unizony, S. | Warrington, K. | +115

4

Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain

enthalten in: Neurobiology of pain (Cambridge, Mass.) | 2023

von Somersan-Karakaya, S. | Turner, K. | Cortes-Burgos, L. | +23

5

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019 : A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial

enthalten in: Open forum infectious diseases | 2023

von Somersan-Karakaya, S. | Mylonakis, E. | Mou, J. | +14

6

Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19

enthalten in: The Journal of infectious diseases | 2022

von Somersan-Karakaya, S. | Mylonakis, E. | Menon, V. | +31

7

Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies

enthalten in: mBio | 2022

von Hooper, A. | Somersan-Karakaya, S. | McCarthy, S. | +12

8

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019 : A Randomized Clinical Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Sivapalasingam, S. | Lederer, D. | Bhore, R. | +37

9

Casirivimab and Imdevimab Treatment in Seropositive, Hospitalized COVID-19 Patients With Non-neutralizing or Borderline Neutralizing Antibodies

enthalten in: bioRxiv.org | 2022

von Hooper, A. | Somersan-Karakaya, S. | McCarthy, S. | +11

10

REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients

enthalten in: bioRxiv.org | 2022

von Weinreich, D. | Sivapalasingam, S. | Norton, T. | +36

1
2
3
4
5
6
7
8
9
Nächster »
[9]